Dennis,
You dont submit a late-breaking abstract to CTAD, the worlds largest and well attended ALZ conference in the world, with just mediocre results. Also, the FDA requiring Anavex to run another P3 trial is the most ridiculous thing circulating. 2-73 is in multiple trials.....Rett, Alz, PDD and has proven to be very safe and effective with almost 90% of patients in all the trials opting for trial extension. . If they beat Biogens Alz drug, which isnt hard to do, it will be approved. Using DNA to find certain DNA that super-responders and responders have in common, the power of the trial doesn't need to be huge like in the past. Those that claim that are about 10 years behind in their thinking, or just trying to spread BS.
As far as NW Bio goes, I suspect application in UK to market DCVax has already been done. Is the ink drying???? Probably.
-Fireman
Market Data 
Markets 
AI
